1-4 of 4
Pablo Tamayo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS

Brian M Reilly, BS, Tiffany N Tanaka, MD, Dinh Diep, PhD, Huwate Yeerna, BS, Pablo Tamayo, PhD, Kun Zhang, PhD, Rafael Bejar, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 106.
https://doi.org/10.1182/blood-2018-99-111535
Published: 2018
Journal Articles

Gene Expression Studies May Identify Lower Risk Myelodysplastic Syndrome Patients Likely to Respond to Therapy with Ezatiostat Hydrochloride (TLK199)

Naomi Galili, Ph.D., Pablo Tamayo, PhD, Olga B Botvinnik, Jill P Mesirov, PhD, Jennifer Zikria, MD, Gail Brown, MD, Azra Raza, MD
Journal: Blood
Blood (2011) 118 (21): 2779.
https://doi.org/10.1182/blood.V118.21.2779.2779
Published: 2011
Journal Articles

Identification of RPS14 as the 5q-Syndrome Gene by RNA Interference Screen.

Benjamin L. Ebert, MD, PhD, Jennifer Pretz, Jocelyn Bosco, Cindy Y. Chang, Pablo Tamayo, PhD, Naomi Galili, PhD, Azra Raza, MD, David Root, PhD, Eyal Attar, MD, Steven R. Ellis, PhD, Todd R. Golub, MD
Journal: Blood
Blood (2007) 110 (11): 1.
https://doi.org/10.1182/blood.V110.11.1.1
Published: 2007
Journal Articles

An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia.

Benjamin L. Ebert, MD, PhD, Naomi Galili, PhD, Pablo Tamayo, PhD, Raymond Mak, Jennifer Pretz, Christine Ladd-Acosta, Richard Stone, MD, Todd R. Golub, MD, Azra Raza, MD
Journal: Blood
Blood (2006) 108 (11): 2668.
https://doi.org/10.1182/blood.V108.11.2668.2668
Published: 2006